Lakefront Biotherapeutics (GLPGF) EBT (QoQ) (2016 - 2026)
Powered by 
Analysis
Lakefront Biotherapeutics (GLPGF) EBT (QoQ) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.55 Bn | 197.56 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.17 Bn | 177.99 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.18 Bn | 124.33 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.50 Bn | 74.50 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.66 Bn | 56.48 Bn | 1.37 Bn |
| 6 | Moderna | 54.61 Bn | 49.47 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.17 Bn | 30.86 Bn | 992.69 Mn |
| 8 | Biogen | 31.36 Bn | 30.07 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.04 Bn | 30.04 Bn | 1.16 Mn |
| 10 | Lakefront Biotherapeutics | 1.73 Bn | 1.73 Bn | 3.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -409.44% |
| Mar 31, 2026 | -100.00% |
| Dec 31, 2025 | 62,267.25% |
| Sep 30, 2025 | -418.01% |
| Jun 30, 2025 | 207.88% |
| Mar 31, 2025 | 94.97% |
| Dec 31, 2024 | -3,095.82% |
| Sep 30, 2024 | -297.29% |
| Jun 30, 2024 | 108.34% |
| Mar 31, 2024 | -99.58% |
| Dec 31, 2023 | 38,871.94% |
| Sep 30, 2023 | -5.26% |
| Jun 30, 2023 | -20.37% |
| Mar 31, 2023 | 99.98% |
| Dec 31, 2022 | -190,768.76% |
| Sep 30, 2022 | 53.52% |
| Jun 30, 2022 | -526.56% |
| Mar 31, 2022 | -375.09% |
| Dec 31, 2021 | 102.28% |
| Sep 30, 2021 | -164.87% |